Health

Biotech Stock Surge on Drug Trial

Updated 2026-05-23 16:05 UTC 1 source Positive

Immunovant's stock surged following positive arthritis trial results for Lilly’s 'triple-G' drug. The FDA leadership changes add to industry uncertainty.

Coverage timeline — 1 article

STAT News

STAT+: Immunovant shares surge on arthritis trial data

Trial results for Lilly's "triple-G" drug, FDA's leadership purge leaves chaos, and more biotech news from The Readout

2026-05-21 16:27 UTC